• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

    52.25 +12.76 (+32.31%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 58,047,933
    Open 52.31
    Bid (Size) 52.27 (300)
    Ask (Size) 52.34 (200)
    Prev. Close 39.49
    Today's Range 52.15 - 52.38
    52wk Range 29.43 - 90.32
    Shares Outstanding 8,168,788
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement ↗
    Neurocrine’s rare-disease push, anchored by Soleno’s VYKAT XR, reshapes biotech dealmaking focus, today, April 6, 2026. 
    Via The Motley Fool
    Topics Intellectual Property Stocks
    News headline image
    Why Soleno Therapeutics Stock Rocketed Higher on Monday ↗
    It's being acquired by a peer. 
    Via The Motley Fool

    Performance

    YTD
    +10.8%
    +10.8%
    1 Month
    +31.7%
    +31.7%
    3 Month
    +15.5%
    +15.5%
    6 Month
    -10.6%
    -10.6%
    1 Year
    -25.0%
    -25.0%

    More News

    Read More
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Soleno Therapeutics, Inc. (Nasdaq – SLNO), Affinity Bancshares, Forian, Inc. (Nasdaq – FORA), Janus Henderson Group plc (NYSE - JHG)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
    Via MarketMinute
    Topics Intellectual Property
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    SLNO Stock Alert: Halper Sadeh LLC is Investigating Whether Soleno Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Why Applied Optoelectronics Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm
    Via TheNewswire.com
    Topics Fraud Lawsuit Retirement
    News headline image
    SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm
    Via NewMediaWire
    Topics Fraud Lawsuit Retirement
    News headline image
    ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    REMINDER: Soleno Therapeutics, Inc. Investors With Significant Losses Must Act By May 5, 2026 – Contact Kirby McInerney
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline
    Via TheNewswire.com
    Topics Fraud Lawsuit Retirement
    News headline image
    Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline
    Via NewMediaWire
    Topics Fraud Lawsuit Retirement
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Frequently Asked Questions

    Is Soleno Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?
    Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?
    The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market
    What is the current price of Soleno Therapeutics, Inc. - Common Stock?
    The current price of Soleno Therapeutics, Inc. - Common Stock is 52.25
    When was Soleno Therapeutics, Inc. - Common Stock last traded?
    The last trade of Soleno Therapeutics, Inc. - Common Stock was at 04/06/26 04:00 PM ET
    What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?
    The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 426.82M
    How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?
    Soleno Therapeutics, Inc. - Common Stock has 427M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.